USER-CENTRIC DIGITAL SOLUTION FOR DIABETIC PATIENTS

Authors

  • Ravindra Bachate
  • Manali Purohit

DOI:

https://doi.org/10.29121/shodhkosh.v5.iICETDA24.2024.1277

Keywords:

Diabetes, User Experience, User-Centric Design

Abstract [English]

Diabetes is a common chronic disorder that affects millions of people globally, necessitating careful management and support. This research paper explores the multifaceted aspects of the user experience (UX) of diabetes patients, understanding their unique needs, challenges, and the potential for improving their quality of life through innovative design solutions. Our research methodology included in-depth interviews, surveys, and user observations, engaging a different types diabetes patients. The insights underscore the significance of personalized, empathetic, and user-centric design in enhancing the UX of diabetes patients. The paper concludes by discussing key recommendations for future design, emphasizing the need for a holistic approach that encompasses both the physical and emotional aspects of diabetes care.

References

Asman AG, Hoogendoorn CJ, McKee MD, Gonzalez JS. Assessing the association of depression and anxiety with symptom reporting among individuals with type 2 diabetes. J Behav Med. 2020 Feb;43(1):57-68. doi: 10.1007/s10865-019-00056-x. Epub 2019 May 20. PMID: 31111355; PMCID: PMC7313241. DOI: https://doi.org/10.1007/s10865-019-00056-x

Faienza MF, Pontrelli P, Brunetti G. Type 2 diabetes and bone fragility in children and adults. World J Diabetes. 2022 Nov 15;13(11):900-911. doi: 10.4239/wjd.v13.i11.900. PMID: 36437868; PMCID: PMC9693736. DOI: https://doi.org/10.4239/wjd.v13.i11.900

Fleming GA, Petrie JR, Bergenstal RM, Holl RW, Peters AL, Heinemann L. Diabetes digital app technology: benefits, challenges, and recommendations. A consensus report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group. Diabetologia. 2020 Feb;63(2):229-241. doi: 10.1007/s00125-019-05034-1. PMID: 31802144. DOI: https://doi.org/10.1007/s00125-019-05034-1

Frommer L, Kahaly GJ. Type 1 diabetes and associated autoimmune diseases. World J Diabetes. 2020 Nov 15;11(11):527-539. doi: 10.4239/wjd.v11.i11.527. PMID: 33269064; PMCID: PMC7672792. DOI: https://doi.org/10.4239/wjd.v11.i11.527

Goyal S, Rani J, Bhat MA, Vanita V. Genetics of diabetes. World J Diabetes 2023; 14(6): 656-679 [PMID: 37383588 DOI: 10.4239/wjd.v14.i6.656] DOI: https://doi.org/10.4239/wjd.v14.i6.656

Mohebi, R., Liu, Y., Hansen, M.K. et al. Insulin growth factor axis and cardio-renal risk in diabetic kidney disease: an analysis from the CREDENCE trial. Cardiovasc Diabetol 22, 176 (2023). https://doi.org/10.1186/s12933-023-01916-2 DOI: https://doi.org/10.1186/s12933-023-01916-2

Monaghan, M., Bryant, B., Inverso, H. et al. Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research. Curr Diab Rep 22, 247–256 (2022). DOI: https://doi.org/10.1007/s11892-022-01465-0

Nakhleh A, Shehadeh N. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention. World J Diabetes. 2021 Dec 15;12(12):2036-2049. doi: 10.4239/wjd.v12.i12.2036. PMID: 35047118; PMCID: PMC8696639. DOI: https://doi.org/10.4239/wjd.v12.i12.2036

Ogurtsova, K., Guariguata, L., Whiting, D. et al. Incorporating uncertainty measurement in the International Diabetes Federation Diabetes Atlas methodology for estimating global and national prevalence of diabetes in adults. Arch Public Health 73 (Suppl 1), P31 (2015). DOI: https://doi.org/10.1186/2049-3258-73-S1-P31

Rayate AS, Nagoba BS, Mumbre SS, Mavani HB, Gavkare AM, Deshpande AS. Current scenario of traditional medicines in management of diabetic foot ulcers: A review. World J Diabetes. 2023 Jan 15;14(1):1-16. doi: 10.4239/wjd.v14.i1.1. PMID: 36684382; PMCID: PMC9850800. DOI: https://doi.org/10.4239/wjd.v14.i1.1

Salvador, D., Bano, A., Wehrli, F. et al. Impact of type 2 diabetes on life expectancy and role of kidney disease among inpatients with heart failure in Switzerland: an ambispective cohort study. Cardiovasc Diabetol 22, 174 (2023). DOI: https://doi.org/10.1186/s12933-023-01903-7

Smith KJ, Pedneault M, Schmitz N. Investigation of anxiety and depression symptom co-morbidity in a community sample with type 2 diabetes: Associations with indicators of self-care. Can J Public Health. 2016 Mar 16;106(8):e496-501. doi: 10.17269/cjph.106.5170. PMID: 26986910; PMCID: PMC6972267. DOI: https://doi.org/10.17269/CJPH.106.5170

Tibiriçá E, Rodrigues E, Cobas R, Gomes MB. Increased functional and structural skin capillary density in type 1 diabetes patients with vascular complications. Diabetol Metab Syndr. 2009 Dec 3;1(1):24. doi: 10.1186/1758-5996-1-24. PMID: 19958533; PMCID: PMC2794258. DOI: https://doi.org/10.1186/1758-5996-1-24

Wang X, Zhao X, Lian T, Wei J, Yue W, Zhang S, Chen Q. Skin autofluorescence and the complexity of complications in patients with type 2 diabetes mellitus: a cross-sectional study. BMC Endocr Disord. 2021 Apr 1;21(1):58. doi: 10.1186/s12902-021-00725-6. PMID: 33794864; PMCID: PMC8017648. DOI: https://doi.org/10.1186/s12902-021-00725-6

Yücel, Ş.Ç., Güler, E.K. & Ak, İ. Investigation of sleep quality, quality of life, anxiety and depression in patients with diabetes mellitus. Int J Diabetes Dev Ctries 35, 39–46 (2015). DOI: https://doi.org/10.1007/s13410-014-0206-y

Downloads

Published

2024-05-31

How to Cite

Bachate, R., & Purohit, M. (2024). USER-CENTRIC DIGITAL SOLUTION FOR DIABETIC PATIENTS. ShodhKosh: Journal of Visual and Performing Arts, 5(ICETDA24), 139–149. https://doi.org/10.29121/shodhkosh.v5.iICETDA24.2024.1277